Cipla USA, Inc. recalls Lanthanum Carbonate chewable tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed stability specifications: Out of specification for hardness test
- Products
-
- Lanthanum Carbonate chewable tablets
- Company
- Cipla USA, Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 1180 boxes
- About this recall
- Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.